- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Oral inhalation flecainide may help restore sinus rhythm in atrial fibrillation patients - Video
Overview
Netherlands: A recent study in the journal Circulation: Arrhythmia and Electrophysiology found the administration of flecainide via oral inhalation to be safe and feasible for the conversion of recent-onset atrial fibrillation to sinus rhythm (SR). Also, it was potentially effective in acute care settings.
Currently, oral and intravenous flecainide is recommended for cardioversion of atrial fibrillation. Harry J G M Crijns, Maastricht University Medical Center and CARIM, Maastricht, the Netherlands, and colleagues aimed to evaluate the feasibility of delivering flecainide via oral inhalation (flecainide acetate inhalation solution) for acute conversion in an open-label, dose-escalation study. The researchers hypothesized that delivery of flecainide by oral inhalation would quickly reach plasma concentrations sufficient for restoring sinus rhythm in patients with recent-onset atrial fibrillation.
For more details, checkout full story on the link mention below
Oral Inhalation Flecainide May Help Restore Sinus Rhythm In Atrial Fibrillation Patients
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)